The Prognostic Significance of Delayed Hypersensitivity to Dinitrochlorobenzene and Mechlorethamine Hydrochloride in Cutaneous T Cell Lymphoma

This publication has 37 references indexed in Scilit:

• The expanding universe of T-cell subsets: Th1, Th2 and more
  Published by Elsevier ,1999
• Progression of Mycosis Fungoides Is Associated with Increasing Cutaneous Expression of Interleukin-10 mRNA
  Journal of Investigative Dermatology, 1996
• The Immune Response to Class I-Associated Tumor-Specific Cutaneous T-Cell Lymphoma Antigens
  Journal of Investigative Dermatology, 1996
• Type 1 and Type 2: a fundamental dichotomy for all T-cell subsets
  Current Opinion in Immunology, 1996
• A patient with plaque-stage mycosis fungoides has successfully been treated with long-term administration of IFN-γ and has been in complete remission for more than 6 years
  British Journal of Dermatology, 1996
• Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
  The Journal of Experimental Medicine, 1993
• Successful interleukin-2 therapy of advanced cutaneous T-cell lymphoma
  British Journal of Dermatology, 1992
• Phase II Study of Recombinant Human Interferon Gamma for Treatment of Cutaneous T-Cell Lymphoma
  JNCI Journal of the National Cancer Institute, 1990
• Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells.
  The Journal of Experimental Medicine, 1989
• Delayed-Type Hypersensitivity in Patients with Mycosis Fungoides
  Dermatology, 1978